Myriad Genetics MYGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$34.1M-34,000% | -$7.9M+81.4% | -$27.4M-24.0% | -$330.5M-801% | -$100K+99.6% | ||
| $12.5M-13.2% | $12.6M-14.9% | $12.6M-19.2% | $14.1M-6.6% | $14.4M-8.3% | ||
| $6.5M-31.6% | $2.8M-74.3% | $12.2M-1.6% | $10.7M-26.2% | $9.5M-20.8% | ||
| $5.4M— | $2.7M-93.7% | $0-100% | $316.7M+2,630% | $0-100% | ||
| $8.7M+1,188% | -$2.6M— | -$19M-332% | $16.2M+2,600% | -$800K-121% | ||
| -$2.7M-400% | —— | $2.9M— | $300K-90.3% | $900K-50.0% | ||
| $5.4M— | -$4.2M— | -$800K— | $3.6M+9.1% | $0-100% | ||
| -$7.4M+40.3% | -$6.7M+75.6% | —— | -$16.8M-205% | -$12.4M+15.1% | ||
| $500K+200% | -$700K-250% | -$600K-167% | -$200K+60.0% | -$500K-150% | ||
| $1.2M+140% | $1.8M+500% | $1.3M+1,200% | $0— | $500K-81.5% | ||
| $1M-64.3% | $1.1M-60.7% | $1M-56.5% | $2.8M+33.3% | $2.8M+21.7% | ||
| -$15.7M+3.7% | $10.6M— | $21.1M— | -$13.6M— | -$16.3M+12.4% | ||
| $1.1M-63.3% | $1.3M-43.5% | $3.4M+21.4% | $4.1M+10.8% | $3M+57.9% | ||
| -$6.5M+21.7% | -$6M-1.7% | -$6.2M— | -$6.9M-7.8% | -$8.3M-16.9% | ||
| $0-100% | —— | —— | —— | $40M-33.3% | ||
| $0-100% | —— | $60M+200% | —— | $20.5M-65.8% | ||
| $100K0.0% | —— | $100K0.0% | $100K0.0% | $100K0.0% | ||
| $2.9M-50.0% | $1.2M0.0% | $300K-90.0% | $0-100% | $5.8M-33.3% | ||
| -$3M-122% | —— | $56.2M+1,913% | $2.6M— | $13.6M+255% | ||
| -$100K-200% | $100K+114% | $0— | $600K+186% | $100K+113% | ||
| -$25.3M-132% | $0— | $71.1M— | -$17.3M-293% | -$10.9M+69.1% | ||
| $5.4M— | $2.7M-93.7% | $0-100% | $316.7M— | $0— | ||
| $9.7M+341% | -$3.3M— | $3.4M+36.0% | -$2.5M— | $2.2M-57.7% | ||
| -$10M-376% | -$1.8M-200% | -$500K— | $0— | -$2.1M-250% | ||
| $0+100% | $64M+1,830% | $0-100% | -$200K-167% | -$31.3M-5,317% | ||
| $1M-64.3% | $1.1M-60.7% | $1M-56.5% | $2.8M+33.3% | $2.8M+21.7% | ||
| $1.1M-63.3% | $1.3M-43.5% | $3.4M+21.4% | $4.1M+10.8% | $3M+57.9% | ||
| $5.4M+1.9% | $4.7M+30.6% | $2.8M-20.0% | $2.8M-46.2% | $5.3M-20.9% | ||
| $100K0.0% | —— | $100K0.0% | $100K0.0% | $100K0.0% | ||
| —— | $1.88M— | $1.88M— | $1.88M— | $1.88M— | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | -$50K+50.0% | -$50K+50.0% | -$50K+50.0% | -$50K+50.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $2.4M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
